Clinical

Articles for Clinical

This week, the top managed care stories included Republicans releasing an outline for replacing the Affordable Care Act, pharmacy benefit managers and pharmaceutical companies pointing fingers over drug costs, and findings on engagement for patients with chronic conditions.
Using body composition metrics to guide the dose in patients receiving anthracyclines-taxane–based chemotherapy for breast cancer can reduce treatment-related toxicity.
At the 5th annual Patient-Centered Oncology Care® meeting, stakeholders shared their views on how bundled payments, clinical pathways, and other value-based approaches can be implemented in cancer care while ensuring adequate care quality.
Population-level judgements on the value of therapies to treat multiple sclerosis don’t adequately depict the differences between how providers and payers view value compared with patients and how patients view value different from one another.
Including anti-cholesterol agents during adjuvant endocrine treatment can prevent breast cancer recurrence in hormone receptor–positive early-stage breast cancer.
Pam Mangat, MS, associate director for the TAPUR study in the research and analysis division of the American Society of Clinical Oncology, offered an update on the study at the 5th annual Patient-Centered Oncology Care® meeting.
Compendia
COPD Compendium
Diabetes Compendium
GI Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
$AD300x250BB$
$vacMongoViewPlus$